Homocysteine, B Vitamins, and the Incidence of Dementia and Cognitive Impairment: Results from the Sacramento Area Latino Study on Aging.
From: Epidemiology Program, School of Public Health, University of Michigan, Ann Arbor, MI 48104, USA. mnhaan@umich.edu
The American journal of clinical nutrition
- Publish Date: Feb 2007
- ISSN: 0002-9165
- Volume: 85
- Issue: 2
- Pages: 511-7
- Medium: Print
- Language: English
- Citation (JAMA): Haan Mary N, Miller Joshua W, Aiello Allison E, et al. Homocysteine, B Vitamins, and the Incidence of Dementia and Cognitive Impairment: Results from the Sacramento Area Latino Study on Aging.. Am. J. Clin. Nutr. Feb 2007;85:511-7
Abstract
BACKGROUND: High concentrations of homocysteine have been linked to a greater risk of Alzheimer disease, dementia, and cognitive decline. OBJECTIVE: We evaluated the association between homocysteine and 4.5-y combined incidences of dementia and cognitive impairment without dementia (CIND) in a cohort of 1779 Mexican Americans aged 60-101 y. DESIGN: Homocysteine, red blood cell (RBC) folate, and plasma vitamin B-12 were measured at baseline. New cases of dementia or CIND were ascertained by neuropsychological and clinical examinations and expert adjudication. We used proportional hazards models to estimate the risk of homocysteine-associated dementia or CIND and the influence of RBC folate and plasma vitamin B-12 on that association. RESULTS: High homocysteine concentrations were associated with a greater risk of dementia or CIND: hazard ratio (HR): 2.39; 95% CI: 1.11, 5.16. Plasma vitamin B-12 modified the association between homocysteine and the outcome. The rates of dementia or CIND associated with homocysteine for those in the lowest and highest tertiles of vitamin B-12, respectively, were significantly higher (HR: 1.61, P = 0.04) and lower (HR: 0.94, P = 0.015) than the risk for those in the middle tertile. CONCLUSIONS: Homocysteine is an independent risk factor for both dementia and CIND. Higher plasma vitamin B-12 may reduce the risk of homocysteine-associated dementia or CIND.
Mesh Headings (Keywords): Aged, Aged, 80 and over, Aging, California, Cognition Disorders, Dementia, Disease Susceptibility, Female, Folic Acid, Health Surveys, Hispanic Americans, Homocysteine, Humans, Incidence, Male, Middle Aged, Risk Factors, Stroke, Vitamin B 12
Check for Full Text / PubMed Unique Identifier (PMID): 17284751
This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.
Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.
The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.